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Abstract
Using the economic complexity methodology on data for disease prevalence in 195 coun-
tries during the period of 1990-2016, we propose two new metrics for quantifying the relat-
edness between diseases, or the ‘disease space’ of countries. With these metrics, we analyze
the geography of diseases and empirically investigate the effect of economic development on
the health complexity of countries. We show that a higher income per capita increases the
complexity of countries’ diseases. Furthermore, we build a disease-level index that links a
disease to the average level of GDP per capita of the countries that have prevalent cases of
the disease. With this index, we highlight the link between economic development and the
complexity of diseases and illustrate, at the disease-level, how increases in income per capita
are associated with more complex diseases.
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1 Introduction
Popular belief holds that the European conquest of America was accomplished with guns and
soldiers. However, Bianchine and Russo [13] show that new illnesses brought from the Old World
by European conquistadors, which resulted in devastating epidemics throughout the New World,
were the major forces behind the aboriginal depopulation of the Americas. Our history, geogra-
phy, culture, religion, and language have often been influenced by infections that have plagued
humankind and shaped important events. Examples include the plague in fourteenth century
Europe, how the yellow fever increased the importation of African slaves in the sixteenth century
due to shortage of indigenous workers and the relative resistance of Africans to the disease, as well
as the typhus deaths of the Napoleon’s army during the 1812 Russian campaign, and Franklin
D. Roosevelt’s hypertension and heart failure, which worsened during his February 1945 dealings
with Joseph Stalin in Malta [86, 95, 103].
Furthermore, there is strong historical evidence that the wealth of nations is positively linked to
the health of their populations. Since the eighteenth century, economic development associated
with improvements in nutrition, access to sanitation, public health interventions, and medical
innovations such as vaccination, have contributed to the reduction of major infectious diseases,
the decline of premature death rates, and a longer life expectancy for children and adults in both
developed and developing countries [14, 39, 40].
Nevertheless, many significant health problems have emerged in concert with economic devel-
opment and technological modernization. Among them, stress, anxiety, sleep deprivation, and
depression are mental disorders that are more prevalent in high-income countries. While they ac-
count for only 9% of the burden in low-income countries, this figure is 18% in middle-income and
27% in high-income countries [88]. In OECD countries, a longer life expectancy is coupled with a
higher rate of chronic and long-term illnesses in older populations [25]. Industrialization has ex-
panded the reach of existing food-related diseases and created new disorders and addictions [26].
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Industrialization also stimulates urbanization, the process of population migration from rural
areas to cities. This makes urban areas focal points for many emerging environmental and health
hazards. According to the World Health Organization (WHO), “as urban populations grow, the
quality of global and local ecosystems, and the urban environment, will play an increasingly im-
portant role in public health with respect to issues ranging from solid waste disposal, provision of
safe water and sanitation, and injury prevention, to the interface between urban poverty, envi-
ronment and health.”.1 Industrialization is also linked to occupational accidents and work-related
diseases (e.g., work-related cancers, musculoskeletal disorders, respiratory diseases, psycho-social
problems, and circulatory diseases), which are worldwide problems resulting in important losses
for individuals, organizations and societies [32, 54, 64, 65, 80, 85, 89, 99, 110].
From the above discussion, it becomes clear that economic development can affect population
health in a number of ways, both positive and negative. To disentangle the net impact of economic
development on countries’ health status, we develop a new metric called the Health Complexity
Index (HCI), which quantifies the disease space of countries, i.e., the network representation
of the relatedness and proximity between diseases with prevalent cases worldwide. To compute
the HCI, we follow the economic complexity methodology, which was initially applied to trade
micro-data, measuring the amount of knowledge materialized in a country’s productive structure.
More, specifically, the Economic Complexity Index (ECI) is a metric that quantifies a country’s
product space, i.e., the network of products traded internationally. When a country produces
a good that is located in the core of the product space, many other related goods can also be
produced with the given capabilities. However, this does not hold for goods lying in the network’s
periphery, because they require different capabilities. The ECI methodology encapsulates this
information by assigning lower values to countries that export products located at the periphery
of the product space and higher values to countries that export commodities located in the center
of the product space [62].
1WHO, ‘Urbanization and health’ https://www.who.int/globalchange/ecosystems/urbanization/en/
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Based on the ECI methodology, a number of recent contributions explain economic development
and growth as a process of information development and of learning how to produce and export
more diversified products [1, 4, 20, 21, 28, 29, 38, 56–58, 61, 62, 91, 93, 102]. Furthermore,
Hartmann et al. [55] have recently shown that countries exporting complex products tend to
be more inclusive and have lower levels of income inequality than countries exporting simpler
products. In addition, Lapatinas and Litina [71] find that countries with high intellectual quotient
(IQ) populations produce and export more sophisticated/complex products, while Lapatinas [70]
shows that the Internet has a positive effect on economic complexity. Adopting the economic
complexity methodology, Balland and Rigby [10] compute a knowledge complexity index with
more than two million patent records for US metropolitan areas between 1975-2010. They analyze
the geography and evolution of knowledge complexity in US cities and show that the most
complex cities in terms of patents are not always those with the highest rates of patenting. In
addition, using citation data, they show that more complex patents are less likely to be cited than
simpler patents when the citing and cited patents are located in different metropolitan areas.
In this paper, we build a complexity index that measures the composition of a country’s pool of
prevalent cases of diseases by combining information on the diversity of diseases in the country
and the ubiquity of its diseases (the number of other countries that also have prevalent cases of
that disease). The intuition is that relatively high scores on the health complexity index indicate
populations that are diverse and have diseases that, on average, have low ubiquity, i.e., these
diseases have prevalent cases in only a few other countries.
In this view, the health complexity index does not refer to a complex treatment or to complex
causes of a disease, but measures instead whether a disease is located in the densely connected
core of the disease space i.e., whether many other related diseases have prevalent cases in many
other countries. The country-disease network and the disease space reveal information about the
health-related habits of populations, such as, lifestyle and dietary habits. There are also multiple
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reasons to expect the disease structures to be associated with their ‘structural transformations’
(i.e., the industrialization process by which economies diversify from agriculture to manufacturing
and services [47, 59, 60, 68, 81]), with their environmental performance [24, 63, 66, 67], or with
their adopted health-related policies [33, 41, 46, 76, 106], as these contribute to their health
status and living standards [42, 75].
The aim of this paper is fourfold: (i) to build two new metrics that quantify the disease space,
following the economic complexity methodology; (ii) to estimate the effect of economic develop-
ment on countries’ health complexity using the new metrics and following dynamic panel data
econometric techniques; (iii) to develop a disease-level index that links a disease to the average
level of GDP per capita of the countries in which the disease has prevalent cases; (iv) to illustrate
how a country’s economic development is associated with changes in its disease composition and
verify the relationship between economic development and health complexity at the disease level.
The remainder of the paper is structured as follows. Section 2 describes the data on disease
prevalence and the construction of the country-disease network and the disease space which form
the analytical backbone of our study. Section 3 presents the methodology for developing the
Health Complexity Index (HCI) and the Disease Complexity Index (DCI). Section 4 presents the
results of the structural analysis of the disease space and the country-disease network, with a
particular focus on countries and regions. Section 5 empirically investigates the effect of economic
development on health complexity using the HCI, data on GDP per capita and potential covari-
ates. Section 6 introduces an index that decomposes economic performance at the disease level.
Using this index, we highlight the link between disease complexity and economic development.
We demonstrate, at the disease level, that better economic performance is associated with more
complex diseases. Finally, in section 7, we offer some concluding remarks.
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2 The country-disease network
2.1 Data on prevalent cases of diseases
Information on diseases comes from the 2016 Global Burden of Diseases (GBD) study by the
Institute for Health Metrics and Evaluation (IHME), an independent population health research
center at UW Medicine (University of Washington) [45] that collects data from various sources
to examine, among other things, the prevalence of diseases and injuries across the world (http:
//www.healthdata.org/).
Diseases and injuries are grouped by causes. The broader classification of causes (level 1) in-
cludes: (a) communicable, maternal, neonatal, and nutritional diseases such as HIV/AIDS and
sexually transmitted infections, respiratory infections and tuberculosis, enteric infections (e.g.,
diarrheal diseases, typhoid fever), neglected tropical diseases (e.g. malaria, chagas disease) and
other infectious diseases (e.g. meningitis and acute hepatitis), maternal and neonatal disorders
(e.g., maternal abortion and miscarriage, ectopic pregnancy, maternal obstructed labor and uter-
ine rupture), nutritional deficiencies (e.g., protein-energy malnutrition, vitamin A, iron, iodine
deficiencies); (b) non-communicable diseases such as cancers, cardiovascular diseases, chronic
respiratory diseases, digestive diseases (e.g., cirrhosis, gastritis, pancreatitis), neurological disor-
ders (e.g., multiple sclerosis, epilepsy, Parkinson’s and Alzheimer’s diseases, migraine), mental
disorders (e.g., schizophrenia, anorexia nervosa and bulimia nervosa, conduct and hyperactiv-
ity disorders), substance use disorders (e.g., alcohol and drug use disorders), diabetes, kidney
diseases, skin diseases (e.g., dermatitis, bacterial skin diseases), sense organ diseases (e.g., glau-
coma, cataract, vision loss), musculoskeletal disorders (e.g., osteoarthritis, rheumatoid arthritis);
(c) injuries such as transport injuries (e.g., pedestrian road injuries, cyclist and motorcyclist road
injuries), unintentional injuries (e.g., falls, poisonings, exposure to mechanical forces), self-harm
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and interpersonal violence (e.g., sexual violence, conflict and terrorism, executions).2
We use information for the most detailed level of causes in the GBD taxonomy (i.e., level 4, and
when there is no level 4 classification, we use level 3). For example, among the non-communicable
diseases (level 1), neoplasms (level 2) include the following level 3 categories: lip and oral cavity
cancer, nasopharynx cancer, other pharynx cancer, esophageal cancer, stomach cancer, colon
and rectal cancer, liver cancer, gallbladder and biliary tract cancer, pancreatic cancer, larynx
cancer, etc. Then, liver cancer includes the following level 4 subcategories: liver cancer due to
hepatitis B, liver cancer due to hepatitis C, liver cancer due to alcohol use, liver cancer due to
non-alcoholic steatohepatitis (NASH), liver cancer due to other causes. In this case, as level 4
categories are available, we consider the information for these categories.
Two measures of disease prevalence are exploited: the rate of prevalence (number of cases per
100,000 population) for all ages, and the age-standardized rate of prevalence to account for the
differences in age structures across countries. This is useful because relative over- or under-
representation of different age groups can obscure comparisons of age-dependent diseases (e.g.,
ischemic heart disease or malaria) across populations.
2.2 The country-disease bipartite network
Instrumental to our analysis is the bipartite network mapping of countries and diseases. Bipartite,
or bi-modal networks are abundant in the scientific literature, with examples including the city-
tech knowledge network [10], the city-firm network [44], firm-projects networks [9], predator-prey
networks [5], plants-pollinator networks [12] etc. Here, we use data from the 2016 Global Burden
of Diseases study that assessed the disease burden of countries in the period of 1990 to 2016,
and we generate an l× k country-diseases matrix E, were the matrix element Ecd represents the
prevalent cases for disease d per 100,000 population in country c.
2In the remainder of the paper we use the word ‘disease’ to refer to all diseases and injuries classified in the GBD
study.
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The aforementioned matrix allows for the construction of an undirected, weighted county-disease
network by linking each disease to the countries that have prevalent cases. These networks are
very dense, and in order to visually explore their structure, we apply the Dijkstra algorithm [30]
to extract a Maximum Spanning Tree (MST) that summarizes their structures. More precisely,
the MST, which is usually considered as the backbone of the network, is a connected subgraph
having l + k − 1 edges with the maximum total weight and without forming any loops.
In Figure 1 we illustrate the country-disease MST for 2016. From this MST, we can easily identify
clusters of countries that are linked to specific types of diseases. The main node of the network is
caries in permanent teeth (disease cause number 682). This disease is the most common disease
across the world, as it is present in the majority of countries. It is also the disease with the
highest number of prevalent cases worldwide (2.44 billion cases in 2016 [45])
2.3 The disease space
The clustering of countries and diseases in the MST of the country-disease network already points
towards relations in the prevalence of different diseases. To explore this further, we construct the
disease space, similar to the product-space introduced by Hidalgo et al. [62]. More precisely, from
the country-disease matrix E, we calculate the ‘relative disease disadvantage’ (RDD) matrix,
as described in the methods section (Section 3). In total, a country c has a relative disease
disadvantage in a particular disease d if the proportion of prevalent cases of disease d in the
country’s total pool of prevalent disease cases is higher than the proportion of prevalent cases of
disease d in the pool of prevalent disease cases in the rest of the world. In this case, RDDcd ≥ 1.
Calculating the RDD for all country-disease pairs allows us to derive a matrix Φ, whose elements
Φi,j define a proximity measure between all pairs of diseases. This proximity measure reveals
diseases that are prevalent in tandem, or in other words, with Φ, we measure the probability
that a country c, which has a relative disease disadvantage in disease i, also has a relative disease
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Figure 1: Maximum Spanning Tree of the country-disease bipartite network. Countries
are represented by yellow nodes, and diseases cover the following categories: [A. ‘Communicable, maternal,
neonatal, and nutritional diseases’] A.1 ‘HIV/AIDS and tuberculosis’, A.2 ‘Diarrhea, lower respiratory, and
other common infectious diseases’, A.3 ‘Neglected tropical diseases and malaria’, A.4 ‘Maternal disorders’, A.5
‘Neonatal disorders’, A.6 ‘Nutritional deficiencies’, A.7 ‘Other communicable, maternal, neonatal, and nutri-
tional diseases’; [B. ‘Non-communicable diseases’] B.1 ‘Neoplasms’, B.2 ‘Cardiovascular diseases’, B.3 ‘Chronic
respiratory diseases’, B.4 ‘Cirrhosis and other chronic liver diseases’, B.5 ‘Digestive diseases’, B.6 ‘Neurological
disorders’, B.7 ‘Mental and substance use disorders’, B.8 ‘Diabetes, urogenital, blood, and endocrine diseases’,
B.9 ‘Musculoskeletal disorders’; [C. ‘Injuries’] C.1 ‘Transport injuries’, C.2 ‘Unintentional injuries’, C.3 ‘Self-
harm and interpersonal violence’, C.4 ‘Forces of nature, conflict and terrorism, and executions and police
conflict’. Data for 2016.
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disadvantage in disease j. The proximity measure is defined as:
Φi,j = min{Pr(RDDi ≥ 1 | RDDj ≥ 1), Pr(RDDj ≥ 1 | RDDi ≥ 1)}, (1)
where Pr(RDDi ≥ 1 | RDDj ≥ 1) is the conditional probability of having a relative disease
disadvantage in disease i if you have a relative disease disadvantage in disease j. Using the
minimum of both conditional probabilities, we avoid issues of a rare disease having prevalent cases
in only one country. Additionally, we make the resulting matrix Φ symmetric (see Figure 2). The
proximity matrix is highly modular and its block structure reveals the presence of ‘communities’,
i.e., groups of diseases that are expected to occur together.
Next, we map this matrix onto a network, where each disease is represented by a node and every
matrix element represents a weighted and undirected link. Similar to the previous section, we
start by applying Dijkstra’s algorithm on matrix Φ which calculates the MST of the network.
Following the rationale of Hidalgo et al. [62], we start from the strongest links that are not part
of the MST and keep adding links to the network until the average degree is four. The resulting
network is a visual representation of the disease space, which is shown in Figure 2.
From Figure 2, it is evident that in the disease space network, different disease categories are
clustered together and, similar to the product space network of Hidalgo et al. [62], the network
is heterogeneous and follows a core-periphery structure. The external part of the network (the
periphery) is mostly dominated by ‘communicable, maternal, neonatal, and nutritional diseases’.
In Section 4, we show that these diseases are mostly prevalent in low-income countries. On the
other hand, the core of the network is dominated by ‘non-communicable diseases’, which have
more prevalent cases in high-income countries (see Figure 3).
10/50
A. Garas, S. Guthmuller, and A. Lapatinas:
The development of nations conditions the disease space
Φ < 0.6Φ < 0.7Φ < 0.8Φ < 0.9Φ < 1.0
A.5
B.1
B.4
A.7
B.3
B.2
B.7
B.5
B.6
A.1
A.4
A.3
A.6
A.2 C.2
B.8
C.1
B.9
C.4
C.3
691
533
847
468
450
532
420419
485
421
441
456
502
693
566
607
471
426
477
647
942
707
723
850
697
849
507
690
649
404
359
341
418
646382
657
706
333
530
336
934
334387
362
363
369
608
361
339
353
335
349
950
348
854
945
947
682
557
644
609
342
698
591
588 511
447
592
329
390
367
402
627
655
628
423
495
674
590
429
500
534
453
632
672
544
630
338352
401
340
320
405
319
394
356 370
946
673
486
484
474
435
432 398
397
371
388
396
681
368
838
941
658
381
954
302
322
615
383
357
395
399
616337
346
935
659
364
598
661
660
545
577
726
513
514
512
648408
710
365
618
652
642
492
529
582
568
715
716
656
692
546
596
562
700
597
699
493
528
711
579
839
578
664
721
576
328
527
654
595
384
675
612
605
665
496
668
679
543
684
631
509 694 559
515498
585
663
685
465
845
414
444
438
944
411
842
639
480
535
525
548
725
727
516
522
619
593
564
569
604
565
547
714
606
683
531
943 524
560 563
523
670
651
643
571
650
645
570
574
705
671
949
358
300
355
351
389
354
948
345
503
936
350
843
938
846 848
459
488
713
403
695
587
837
708
483
662
573
554
729
614
Figure 2: The proximity matrix and the resulting disease space. The size of the nodes is
proportional to their degree, i.e., the number of links. Disease colors cover the following categories: [A. ‘Com-
municable, maternal, neonatal, and nutritional diseases’] A.1 ‘HIV/AIDS and tuberculosis’, A.2 ‘Diarrhea, lower
respiratory, and other common infectious diseases’, A.3 ‘Neglected tropical diseases and malaria’, A.4 ‘Maternal
disorders’, A.5 ‘Neonatal disorders’, A.6 ‘Nutritional deficiencies’, A.7 ‘Other communicable, maternal, neonatal,
and nutritional diseases’; [B. ‘Non-communicable diseases’] B.1 ‘Neoplasms’, B.2 ‘Cardiovascular diseases’, B.3
‘Chronic respiratory diseases’, B.4 ‘Cirrhosis and other chronic liver diseases’, B.5 ‘Digestive diseases’, B.6 ‘Neu-
rological disorders’, B.7 ‘Mental and substance use disorders’, B.8 ‘Diabetes, urogenital, blood, and endocrine
diseases’, B.9 ‘Musculoskeletal disorders’; [C. ‘Injuries’] C.1 ‘Transport injuries’, C.2 ‘Unintentional injuries’, C.3
‘Self-harm and interpersonal violence’, C.4 ‘Forces of nature, conflict and terrorism, and executions and police
conflict’. Data for 2016.
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Figure 3: Localization of diseases for different income-regions of the world. A: High
income, B: Upper-middle income, C: Lower-middle income, D: Low income. Diseases in an income-region where
more than half of the countries belonging to this region have a RDD>1 are shown with black nodes in the
disease space network. Data for 2016.
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3 Methods
3.1 Health complexity index
To calculate health complexity and disease complexity, we combine information on prevalent
cases of diseases and how common these diseases are across countries, following the economic
complexity methodology, i.e., the formulas in the pioneering work of Hidalgo and Hausmann
[61]. In short, let us assume that we have disease information for l number of countries and k
diseases. With this information, we can fill an l × k diseases matrix E, so that matrix element
Ecd is country c’s information for disease d. If there is no information for disease d in country c,
then Ecd = 0. From this matrix, it is easy to calculate the following ratio:
RDDcd =
Xcd/
∑
d′ Xcd′∑
c′ Xc′d/
∑
c′d′ Xc′d′
, (2)
where Xcd is the number of prevalent cases of disease d per 100,000 population in country c.
Similar to the economic complexity methodology and the discussion in [21, 55, 61], we claim that
a country has a relative disease disadvantage in a disease when RDDcd ≥ 1. In other words, a
country c has a RDD in disease d if the proportion of prevalent cases of disease d in the country’s
pool of all prevalent cases of disease is higher than the proportion of prevalent cases of disease d
in the world’s pool of all prevalent cases of disease.
Using this threshold value, we obtain the l × k matrix M, with matrix elements Mcd = 1 if
country c has a RDD in disease d, and zero otherwise. A visualization of the matrix M that is
used to calculate the HCI and the DCI for this dataset is shown in Figure 8. From this matrix,
similar to Hidalgo and Hausmann [61], we introduce the HCI as a measure of countries’ disease
structures. To obtain the HCI, we first calculate the l × l square matrix M˜. In short, matrix M˜
provides information about links connecting two countries c and c′, based on the prevalent cases
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of diseases in both. The matrix elements M˜cc′ are computed as
M˜cc′ =
1
kc,0
∑
p
McdMc′d
kp,0
, (3)
where kc,0 =
∑
dMcd measures the diversification of country c in terms of its different diseases,
and kd,0 =
∑
cMcd measures the number of countries with information on prevalent cases of
disease d. If K is the eigenvector of M˜ associated with the second largest eigenvalue, then
according to Hausmann et al. [57], the HCI is calculated as
HCI =
K− 〈K〉
std(K)
. (4)
The HCI reflects the disease-composition of a country’s pool of diseases, taking into account the
composition of the pools of all other countries. Populations with diseases that have prevalent
cases of diseases that occur in many other countries have relatively low health complexity scores,
while more health-complex countries have a high prevalence of non-ubiquitous diseases. In other
words, a country has a complex disease composition, i.e., it is health-complex, if its diseases
have high prevalence in only a few other countries. The HCI is higher for countries with diseases
located at the core of the ‘disease-space’ and lower for countries with diseases located at the
periphery of the ‘disease-space’.
3.2 Disease complexity index
In a similar manner, but placing the spotlight on diseases rather than countries, we can calculate
the Disease Complexity Index (DCI). In this case, the k × k matrix M˜ provides information
about links connecting two diseases d and d′, based on the number of countries in which both
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diseases have prevalent cases. Therefore, the matrix elements M˜dd′ are computed as
M˜dd′ =
1
kd,0
∑
c
McdMcd′
kc,0
, (5)
and if Q is the eigenvector of M˜ associated with the second largest eigenvalue,
DCI =
Q− 〈Q〉
std(Q)
. (6)
Table 1: List of the five diseases with the highest and lowest DCI values during the period of
1990-2016
Code Disease name Disease section DCI
Highest DCI
459 Malignant skin melanoma Neoplasms 1.210
441 Colon and rectal cancer Neoplasms 1.170
502 Peripheral artery disease Cardiovascular diseases 1.169
456 Pancreatic cancer Neoplasms 1.159
533 Vascular intestinal disorders Neurological disorders 1.152
Lowest DCI
345 Malaria Neglected tropical diseases and malaria -2.045
350 African trypanosomiasis Neglected tropical diseases and malaria -1.978
370 Maternal obstructed labor and uterine rupture Maternal and neonatal disorders -1.957
358 Yellow fever Neglected tropical diseases and malaria -1.893
340 Tetanus Other infectious diseases -1.883
Notes: DCI: Disease Complexity Index; Average values for 1990-2016
As discussed above, the HCI and DCI are computed using in Xcd the number of prevalent cases
of a disease (according to cause levels 3 or 4) per 100,000 population for 195 countries and for 196
diseases. The time-period covered is from 1990 to 2016. With the age-standardized data (see the
discussion in Section 2.1), we also calculate the age-standardized health complexity index (AHCI)
and the age-standardized disease complexity index (ADCI) by following the same formulas. We
use the two indices as alternative measures when checking the robustness of our results. It should
be noted here that the computation of the indices is based only on diseases for which a country
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has a RDD in terms of disease prevalence (the incidence matrix of the bipartite network linking
countries to diseases, M, reflects whether or not a country has a RDD in a specific disease; see
Figure 8). Table 1 lists the five diseases with the highest and lowest DCI scores averaged over
the period of 1990-2016.
4 The geography of complex diseases
Figure 3 shows the patterns of disease specialization for the world’s economies, classified by the
World Bank into four income groups - ‘high’, ‘upper-middle’, ‘lower-middle’, and ‘low’. Diseases
in a region where more than half of its countries have a RDD > 1 are shown with black nodes.
It seems that high-income countries occupy the core, composed of ‘non-communicable diseases’
such as ‘pancreatic cancer’, ‘Parkinson disease’, ‘ischemic stroke’ and injuries such as ‘falls’, ‘poi-
sonings‘ and ‘other exposure to mechanical forces’. On the other side of the spectrum, low-income
countries tend to have a RDD in ‘communicable, neonatal, maternal and nutritional diseases’ that
lie in the periphery of the disease space such as ‘diarrheal diseases’, ’encephalitis’ and ‘malaria’.
Most of the communicable diseases for which low-income countries have a RDD > 1 also appear
in the periphery (for example, ‘Turner syndrome’, ‘neural tube defects’ and ‘pyoderma’). Exam-
ples of injuries for which low-income countries have a RDD include ‘venomous animal contact’
and ‘sexual violence’, which again appear in the periphery of the disease space.
The above descriptive findings are also observable in Figure 4, where we map the spatial variation
in complex diseases. This figure shows the repartition of the HCI across countries when taking
average values for the period 1990-2016. We see rather clearly that disease complexity is unevenly
distributed in the world and that the most complex countries in terms of diseases seem to be
located in Europe, North America, and Australia – European countries, Australia, the US, and
Canada belong to the set of countries with the highest HCI (>80%). In contrast, most countries
in Africa have much lower HCIs on average.
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Figure 4: Health complexity index across the world. Mean values for the period 1990-2016:
percentile repartition. Countries depicted in dark red have a mean value above the 80th percentile.
Taking a closer look at differences between particular countries, Figure 5 displays the disease
maps of Portugal and the Democratic Republic of the Congo (DRC), which have the highest and
lowest HCI scores (in 2016) respectively. The two countries strongly differ in the composition of
their diseases. Portugal has a disease structure in which, out of all prevalent cases of disease,
the proportion of non-communicable diseases (97.8%) is more than double that of communicable
diseases (42.4%). The non-communicable diseases with relatively high proportions of prevalent
cases include ‘tension headache’ (37.5%), ‘permanent caries’ (36.2%), ‘migraine’ (23.8%) and ‘age-
related hearing loss’ (22.8%). In the communicable, neonatal, maternal and nutritional diseases
category (red), ‘genital herpes’ (13.2%), ‘latent TB infection’ (10.4%) and ‘dietary iron deficiency’
(7.9%) are the diseases with the highest proportion of prevalent cases. Regarding prevalent cases
of injuries (green), Portugal’s proportion of total cases in the country is 29%, while the respective
rate for the DRC is only 13.6%.
The distribution of diseases in the DRC is more uniform: communicable, neonatal, maternal
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and nutritional diseases comprise 89.5% of total prevalent cases of diseases, and this figure is
comparable to the proportion of non-communicable diseases (93.1%). For the DRC, ‘vitamin A
deficiency’ (23.5%), ’malaria’ (22.9%) and ‘schistosomiasis’ (21.2%) are the diseases with the
highest proportion of prevalent cases out of all cases of diseases in the country.
The above ‘structural’ differences are captured by the HCI. Communicable, neonatal, maternal
and nutritional diseases are, on average, less complex than non-communicable diseases, because
the former lie in the periphery of the disease space, while the latter constitute its core. Hence the
DRC receives a lower HCI value compared to Portugal, because in its population, the proportion
of communicable, neonatal, maternal and nutritional diseases is higher.
Regarding the evolution of HCI scores over time, figures 6 and 7 depict how health complexity in
our sample of countries has changed from 1990-1996 to 2010-2016. Cambodia, Myanmar, Nepal,
Vietnam, Saint Lucia and Cameroon have registered significant increases in the complexity of
their diseases. On the other hand, the diseases of countries like Vanuatu, Kiribati, Palestine,
Tajikistan and Gabon are now less complex than in the early 1990s. Figure 7 depicts the same
information in a world map. Blue and light blue colors depict a decrease in HCI score, while
orange and red colors denote countries with an increase in HCI score from 1990-1996 to 2010-
2016. From these figures, it can be observed that changes over time are rather small. Hence, it
seems that a country’s HCI score tends to persist through time, which is to be expected for a
metric of prevalent cases of diseases aggregated at the country level. This motivates the inclusion
of the lagged value of HCI in the set of explanatory variables when estimating the effect of
economic development on health complexity in the next section.
5 The effect of economic development on health complexity
We study the effect of economic development on health complexity using data on GDP per capita
(from the World Bank’s World Development Indicators) and the HCI (see Section 3). Given the
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(a)
(b)
Figure 5: The disease maps of two countries. [a] Portugal [b] The Democratic Republic of
the Congo. Number of prevalent cases per 100,000 population (in 2016) by type of disease: communica-
ble, neonatal, maternal and nutritional diseases (red), non communicable diseases (blue), and injuries
(green). Portugal is the country with the highest health complexity index in 2016. The Democratic Re-
public of the Congo is the least health-complex country in 2016. Source: GBD Compare, IHME Viz Hub,
http://www.healthdata.org/results/data-visualizations.
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Figure 6: Evolution of the health complexity index over time. Changes in the health
complexity index from 1990-1996 to 2010-2016. The labelled black dots are the 10 countries with the largest
changes over time.
availability of controls, the sample covers a minimum of 168 developed and developing countries
over the period of 1992-2015. 3
3Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbai-
jan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and
Herzegovina, Botswana, Brazil, Brunei, Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia,
Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Rep. of the Congo, Costa
Rica, Cote d’Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Arab Rep. of
Egypt, El Salvador, Equatorial Guinea, Estonia, Eswatini, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Geor-
gia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary,
Iceland, India, Indonesia, Islamic Rep. of Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan,
Kenya, Kiribati, Rep. of Korea, Kuwait, Kyrgyz Republic, Lao PDR, Latvia, Lebanon, Lesotho, Liberia, Libya,
Lithuania, Luxembourg, Macedonia FYR, Madagascar, Malawi, Malaysia, Maldives, Malta, Mauritania, Mauri-
tius, Mexico, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands,
New Zealand, Nicaragua, Niger, Nigeria, Norway, Oman, Pakistan, Panama, Papua New Guinea, Paraguay,
Peru, Philippines, Poland, Portugal, Qatar, Russian Federation, Rwanda, Samoa, Sao Tome and Principe, Saudi
Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovak Republic, Slovenia, South Africa, Spain, Sri
Lanka, St. Lucia, St. Vincent and the Grenadines, Sudan, Suriname, Sweden, Switzerland, Tajikistan, Tanzania,
Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, United
Kingdom, United States, Uruguay, Vanuatu, Venezuela RB, Vietnam, Rep. of Yemen, Zambia, Zimbabwe.
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Figure 7: Changes in the health complexity index across the world. Changes in HCI
scores (percentile repartition) from the period 1990-1996 to 2010-2016. Countries depicted in light blue and
blue (orange and red) have experienced a decrease (increase) in HCI score below and above the median de-
crease (increase), respectively.
5.1 Regression analysis
Previous research shows that there is a strong positive association between income and indica-
tors of population health such as life expectancy and child mortality. There are various channels
through which economic development can stimulate health improvements, for example, via its
effect on nutrition (which in turn leads to better resistance to bacterial diseases and faster recov-
ery from illnesses), as well as through greater labor market participation, worker productivity,
investment in human capital, investment in public and private health services, savings, fertility,
transportation infrastructure, and lifestyle habits. [6, 16, 17, 35, 43, 53, 73, 83, 87, 96].4 The term
‘diseases of affluence’ refers to selected diseases and health conditions that are more prevalent
in wealthy nations. Examples include mostly non-communicable diseases such as cardiovascular
diseases and their nutritional risk factors (overweight and obesity, elevated blood pressure and
4For a review of the empirical evidence see [69].
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cholesterol). It has been shown that economic development is a robust predictor of ‘diseases of
affluence’ [36, 50, 79, 90, 109]. However, there is also a large and growing literature that inves-
tigates the reverse channel, i.e., that better population health leads to economic development
[2, 15]. The argument is that improved health conditions increase population size, which – in the
medium term – leads to more people entering the labor force, higher capital accumulation, and
higher income per capita.
In order to estimate the effect of economic development on the health complexity of countries
we follow a fixed-effects two-stage least squares/instrumental variables (FE 2SLS/IV) strategy,
complemented with a difference Generalized Method of Moments (diff-GMM) approach. We
regress the baseline specification described by the following equation:
HCIi,t = ρHCIi,t−1 + β1GDPpci,t + βkcontrolsi,t + γi + δt + ui,t. (7)
Here, the health complexity of country i in period t (HCIi,t) depends on the country’s level of
economic development in per capita terms (in logs), GDPpci,t. The lagged value of the dependent
variable on the right-hand side is included to capture persistence in health complexity. The main
variable of interest isGDPpc. The parameter β1 therefore measures the effect of income per capita
on health complexity.5 Additional potential covariates are included in the vector controlsi,t. The
γi’s denote a full set of country dummies and the δt’s denote a full set of time effects that
capture common shocks to the health complexity scores of all countries. The error term ui,t
captures all other omitted factors, with E(ui,t) = 0 for all i and t. To examine the robustness
of our results and to generalize our findings, we replicate our analysis for additional/alternative
control variables and substitute the HCI with the AHCI, finding qualitatively similar results (see
5In order to account for possible changes in the relation between economic development and health complexity
over the process of economic development, we have experimented with the inclusion of the quadratic specification
of GDP per capita in the estimated equation. Our baseline results (which are available upon request) do not
confirm a U-shaped relationship between economic development and health complexity.
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subection 5.2).
Table 2: Variable definitions, sources and summary statistics
Variable Definition Source Mean Std. Dev.
HCI Health Complexity Index. Authors’ calculations -0.006 1.004
HCI+ age-standardized Health Complexity Index. Authors’ calculations -0.008 1.008
GDPpc (log) GDP per capita, PPP (constant 2011 inter-
national $)
World Development Indicators 8.342 1.521
old (log) Population aged 65 and above (% of total) World Development Indicators 1.764 0.667
female (log) Female population (% of total) World Development Indicators 3.912 0.067
urban (log) Urban population (% of total) World Development Indicators 3.871 0.519
agriculture (log) Agriculture, value added (% of GDP) World Development Indicators 2.054 1.228
manufacturing (log) Manufacturing, value added (% of GDP) World Development Indicators 2.407 0.591
education (log) Enrollment in secondary education, both
sexes (total)
World Development Indicators 4.229 0.587
population
density
(log) Population density (people per sq. km of
land area)
World Development Indicators 4.123 1.398
CO2 (log) CO2 emissions (kg per 2010 $US of GDP) World Bank -0.930 0.704
health ex-
penditure
(log) Total health spending, PPP (thousands of
2017 $US)
Global Health Spending 1995-2015, IHME 15.071 2.239
economic
globalization
Actual flows (trade, foreign direct investment,
stocks, portfolio investment, income payments
to foreign nationals), restrictions (hidden import
barriers, mean tariff rate, taxes on international
trade, capital account restrictions). Higher values
reflect greater economic globalization.
KOF Index of Globalization 54.462 16.234
political
globalization
Embassies in country, membership in international
organizations, participation in UN security coun-
cil missions, international treaties. Higher values
reflect greater political globalization.
KOF Index of Globalization 62.283 21.985
5.1.1 Control Variables
We include in the estimated equation a number of control variables that are likely related to
health complexity.
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The proportion of nations’ populations over the age of 65 has been increasing in recent years
and will continue to rise in future as a result of longer life expectancy. Population age-structure
is a significant determinant of a nation’s health status, due to age-related diseases (i.e., illnesses
and conditions that occur more frequently in people as they get older). Examples of age-related
diseases include cardiovascular and cerebrovascular diseases, hypertension, cancer, Parkinson’s
disease, Alzheimer’s disease, osteoarthritis and osteoporosis. Demographic factors such as age and
sex are considered key covariates in the study of human health and well-being, hence the per-
centage of old population (aged 65 and above, in logs) and the percentage of female population
(in logs) are included in the set of control variables.
It has previously been shown that sex interacts with social, economic and biological determinants
to create different health outcomes for males and females. For example, Vlassoff [104] reviews a
large number of studies on the interaction between sex and the determinants and consequences
of chronic diseases, showing how these interactions result in different approaches to prevention,
treatment, and coping with illness.
In our analysis, we also control for the (log) percentage of urban population, urban. According to
theWorld Health Organization (WHO), a large proportion of non-communicable diseases is linked
to risks related to the urban environment, such as physical inactivity and obesity, cardiovascular
and pulmonary diseases from transport-generated urban air pollution, ischemic heart disease and
cancers from household biomass energy use, asthma from indoor air pollution, and heat-related
strokes and illnesses. In addition, communicable diseases such as tuberculosis, dengue fever, and
many respiratory and diarrheal diseases result from unhealthy urban environments (e.g. lack of
adequate ventilation, unsafe water storage and poor waste management, indoor air pollution,
moldy housing interiors, poor sanitation).6
Industrialization, i.e., the structural transformation from agricultural to industrial production
6See WHO, Health and sustainable development: About health risks in cities, https://www.who.int/
sustainable-development/cities/health-risks/about/en/
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also has a range of significant health implications [23, 77, 97, 98, 101]. We capture these impli-
cations in our analysis by including the (log) value added of agriculture (% of GDP) and the
(log) value added of manufacturing (% of GDP) in the estimated equation.
To check the robustness of our baseline results, we replicate our analysis controlling also for the
human capital of the population by utilizing total enrolment in secondary education (in logs). It
is well established in the relevant literature that through education, people gain the ability to be
effective in their lives. They adopt healthier lifestyles and inspire their offspring to do as well [78].
Individuals with higher levels of education also tend to have better socioeconomic resources for a
healthy lifestyle and a higher probability of living and working in healthy environments [3, 18]. In
addition, educated individuals tend to have lower exposure to chronic stress [84]. Low educational
attainment, on the other hand, is associated with a shorter life expectancy, poor self-reported
health, and a high prevalence of infectious and chronic non-infectious diseases [37, 51, 72, 108].7
Furthermore, we re-estimate the baseline model by substituting urban with population density
(people per square km of land, in logs).
The variable CO2 (log of CO2 emissions in kg per 2010 $US of GDP) captures the effect of
air pollution on health, which has been the subject of numerous studies in recent years (for an
extensive review, see [19]).
Finally, health expenditure (log of total health spending in thousands of purchasing power parity
(PPP)-adjusted 2017 $US) is also included in the set of explanatory variables controlling for the
association between healthcare spending and health outcomes [11, 27, 74, 82, 94, 105, 107, 111]
Data definitions, sources and summary statistics for the variables included in the analysis are
given in Table 2.
7Grossman [49] and Ross and Wu [92] review the relationships between education and a wide variety of health
measures.
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5.1.2 Instrumental variables
We estimate equation (7) using different econometric methods. First, we use fixed-effects OLS.
However, fixed effects estimators do not necessarily identify the effect of economic development
on health complexity. The estimation of causal effects requires exogenous sources of variation.
While we do not have an ideal source of exogenous variation recognized by previous studies,
there are two promising potential instruments of economic development that we adopt in our
fixed-effects 2SLS/IV and diff-GMM analyses.
First, we use the KOF Swiss Economic Institute’s economic globalization index, characterized as
the flows of goods, capital, and services, as well as information and perceptions that accompany
market exchanges [31]. Higher values reflect greater economic globalization.
The second instrument considered is the KOF Swiss Economic Institute’s political globalization
index, characterized by the number of embassies in a country, its membership in international
organizations, its participation in UN security council missions and international treaties. Higher
values reflect greater political globalization.
There is extensive research documenting the positive relationship between globalization and
economic development and growth [22, 31, 34, 48, 52]. While we do not have a precise theory to
support the prediction, it is expected that changes in the economic globalization and political
globalization indices have no direct effect on a country’s disease structure and impact health
complexity only indirectly, through the channel of economic development. This point is also
verified in our dataset, as we find no correlation between HCI scores and these two variables (the
results are available upon request).
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Table 3: The effect of economic development on health complexity: Fixed-effects OLS
(1) (2) (3) (4) (5) (6)
HCIt−1 0.938*** 0.938*** 0.938*** 0.933*** 0.929*** 0.929***
(0.009) (0.009) (0.010) (0.010) (0.010) (0.010)
GDPpc 0.013*** 0.013*** 0.013*** 0.012*** 0.009** 0.011***
(0.003) (0.003) (0.003) (0.003) (0.003) (0.004)
old -0.001 -0.001 0.002 0.000 0.002
(0.006) (0.006) (0.006) (0.007) (0.007)
female -0.014 -0.013 0.002 -0.006
(0.024) (0.024) (0.023) (0.024)
urban 0.020** 0.025*** 0.021**
(0.008) (0.008) (0.009)
agriculture -0.006*** -0.006***
(0.002) (0.002)
manufacturing 0.001
(0.002)
Observations 4,750 4,593 4,593 4,593 4,377 4,181
Countries 190 183 183 183 180 177
R-squared 0.873 0.874 0.874 0.875 0.872 0.872
Note: Dependent variable: Health Complexity Index (HCI). Main independent variable: GDP per capita
in logs (GDPpc). Time fixed-effects are included in all regressions. Robust standard errors are in paren-
theses. * p<0.10, ** p<0.05, *** p<0.01
5.2 Regression results
In this section, we discuss the results of estimating equation (7) with different econometric
techniques. Table 3 reports the results of fixed-effects ordinary least squares (FE-OLS) with
time dummies, adding an additional variable from the set of controls in each step (column). In
all specifications, economic development has a positive relationship with health complexity, and
the control variables enter with the expected sign. The agriculture coefficient is negative, and
countries with a higher proportion of urban population exhibit greater health complexity.
The results depicted in Table 3 could only be interpreted as correlations. For a robust analysis
accounting for the potential endogeneity problem in the relationship under consideration (dis-
cussed above), we use fixed-effects 2SLS/IV estimation techniques complemented with diff-GMM
estimations à la Arellano-Bond [8]. Table 4 presents our baseline results.
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In columns (1)-(8), we estimate equation (7) with FE 2SLS/IV regressions. We use time dummies
and robust standard errors (in parentheses). In all cases, GDPpc is a positive and statistically
significant predictor of health complexity. In fact, we find that an increase in GDP per capita of
10% is associated with an improvement of about 0.003 in the HCI (standard deviation: 1.004).
This positive impact of economic development on health complexity is robust to the inclusion
of control measures discussed in subsection 5.1.1. The statistically significant urban coefficient
implies that a higher proportion of urban population is associated with more complex diseases.
In the fixed effects 2SLS/IV estimations we report: (a) the F -test for the joint significance of
the instruments in the first stage: the rule of thumb is to exceed 10, hence the test implies weak
significance [100]; (b) the Durbin-Wu-Hausmann (DWH) test for the endogeneity of regressors:
the null hypothesis that the IV regression is not required is rejected; (c) the Cragg-Donald F-
statistic (Weak-id), testing the relevance of the instruments in the first-stage regression: no
evidence of a low correlation between instruments and the endogenous regressor is found after
controlling for the exogenous regressors; (d) the Kleibergen-Paap Wald test (LM -weakid) of
weak identification: the null hypothesis that the model is weakly identified is rejected; (e) the
p-value for Hansen’s test of overidentification: the acceptance of the null indicates that the
overidentifying restrictions cannot be rejected.
In column (9) of Table 4 we report the diff-GMM estimations including year fixed effects and
robust standard errors. The results verify the previous findings both qualitatively and quanti-
tatively, i.e., the estimated coefficient of GDPpc implies an improvement of 0.003 in the HCI
with a GDP per capita increase of 10%. Among the control variables, only the urban variable
has a statistically significant and positive sign. The values reported for AR(1) and AR(2) are
the p-values for first- and second-order autocorrelated disturbances. As expected, there is high
first-order autocorrelation and no evidence for significant second-order autocorrelation. Hence,
our test statistics hint at a proper specification.
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Table 4: The effect of economic development on health complexity: baseline results
(1) (2) (3) (4) (5) (6) (7) (8) (9)
FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV diff-GMM
HCIt−1 0.926*** 0.927*** 0.927*** 0.923*** 0.923*** 0.922*** 0.922*** 0.921*** 0.814***
(0.010) (0.010) (0.010) (0.010) (0.010) (0.010) (0.011) (0.010) (0.061)
GDPpc 0.031*** 0.031*** 0.031*** 0.031*** 0.026** 0.029*** 0.030* 0.027** 0.032**
(0.011) (0.011) (0.011) (0.011) (0.011) (0.011) (0.017) (0.013) (0.013)
old -0.003 -0.002 -0.001 -0.003 -0.001 -0.002 -0.001 -0.005
(0.005) (0.005) (0.005) (0.006) (0.006) (0.006) (0.006) (0.017)
female -0.015 -0.015 -0.019 -0.029 -0.031 -0.026 0.029
(0.023) (0.023) (0.027) (0.028) (0.033) (0.029) (0.044)
urban 0.013 0.020*** 0.017** 0.017** 0.017** 0.031*
(0.008) (0.008) (0.008) (0.009) (0.008) (0.018)
agriculture -0.003 -0.003 -0.002 -0.003 -0.002
(0.003) (0.003) (0.004) (0.003) (0.008)
manufacturing 0.002 0.002 0.002 -0.003
(0.002) (0.002) (0.002) (0.012)
Fist-stage results
economic globalization 0.003*** 0.003*** 0.003*** 0.003*** 0.004*** 0.003*** 0.005***
(0.001) (0.001) (0.001) (0.001) (0.000) (0.000) (0.000)
political globalization 0.004*** 0.004*** 0.004*** 0.004*** 0.004*** 0.005*** 0.006***
(0.001) (0.001) (0.001) (0.001) (0.000) (0.000) (0.000)
Observations 4,168 4,143 4,143 4,143 3,976 3,826 3,826 3,926 3,652
Countries 171 170 170 170 170 168 168 173 168
F-test 37.24 37.05 36.31 39.93 56.26 61.41 79.18 76.56
DWH-test 2.978 2.911 2.785 3.073 2.500 2.646 1.304 1.523
Weak-id 59.73 54.25 54.88 56.82 97.43 107.0 104.3 152.6
LM-weakid 71.12 70.95 69.68 75.01 109.7 116.3 72.90 73.98
Hansen (p-value) 0.590 0.699 0.676 0.897 1.000 0.904
AR(1) 0.000
AR(2) 0.475
Note: Dependent variable: Health Complexity Index (HCI). Main independent variable: GDP per capita in logs (GDPpc). Columns (1)-(8): Fixed-effects 2SLS/IV; HCI is instru-
mented: To save space, we only include the first-stage estimated coefficients of the instruments. The results for the rest of the variables are available upon request. Column (9):
One-step diff-GMM. All regressions include time dummies. Robust standard errors are in parentheses. F-test gives the F-statistic for the joint significance of the instruments in the
first stage. DWH-test is the Durbin-Wu-Hausman test of endogeneity of the regressors. Weak-id gives the Cragg-Donald F-statistic for weak identification. LM-weakid gives the
Kleibergen-Paap Wald test of weak identification. Hansen (p-value) gives the p-value of the Hansen test of overidentification. AR(1) and AR(2) are the p-values for first- and second-
order autocorrelated disturbances. * p<0.10, ** p<0.05, *** p<0.01
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Table 5: The effect of economic development on health complexity: AHCI
(1) (2) (3) (4)
FE 2SLS/IV FE 2SLS/IV FE 2SLS/IV diff-GMM
AHCIt−1 0.923*** 0.925*** 0.919*** 0.828***
(0.011) (0.012) (0.011) (0.114)
GDPpc 0.037*** 0.033** 0.041*** 0.024*
(0.011) (0.015) (0.014) (0.013)
female -0.028 -0.021 -0.037 0.030
(0.027) (0.034) (0.031) (0.040)
urban 0.009 0.010 0.007 0.011
(0.007) (0.008) (0.008) (0.023)
agriculture 0.002 0.001 0.003 0.008
(0.003) (0.004) (0.004) (0.010)
manufacturing 0.002 0.002 0.003 -0.013
(0.002) (0.002) (0.002) (0.011)
Fist-stage results
economic globalization 0.004*** 0.005***
(0.000) (0.000)
political globalization 0.004*** 0.005***
(0.000) (0.000)
Observations 3,826 3,826 3926 3,652
Countries 168 168 173 168
F-test 67.39 101.5 71.22
DWH-test 6.055 2.200 4.548
Weak-id 116.2 136.4 138.9
LM-weakid 125.8 92.43 67.20
Hansen (p-value) 0.681
AR(1) 0.000
AR(2) 0.158
Note: Dependent variable: Age-standardized Health Complexity Index (AHCI). Main indepen-
dent variable: GDP per capita in logs (GDPpc). Columns (1)-(3): Fixed-effects 2SLS/IV; AHCI
is instrumented: To save space, we only include the first-stage estimated coefficients of the instru-
ments. The results for the rest of the variables are available upon request. Column (4): One-step
diff-GMM. All regressions include time dummies. Robust standard errors are in parentheses. F-test
gives the F-statistic for the joint significance of the instruments in the first stage. DWH-test is the
Durbin-Wu-Hausman test of endogeneity of the regressors. Weak-id gives the Cragg-Donald F-
statistic for weak identification. LM-weakid gives the Kleibergen-Paap Wald test of weak identifica-
tion. Hansen (p-value) gives the p-value of the Hansen test of overidentification. AR(1) and AR(2)
are the p-values for first- and second-order autocorrelated disturbances. * p<0.10, ** p<0.05, ***
p<0.01
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Table 6: The effect of economic development on health complexity: robustness checks
(1) (2) (3) (4) (5)
diff-GMM diff-GMM diff-GMM diff-GMM diff-GMM
HCIt−1 0.752*** 0.871*** 0.812*** 0.920*** 0.666***
(0.059) (0.046) (0.063) (0.040) (0.062)
GDPpc 0.031* 0.031*** 0.024* 0.042*** 0.038*
(0.016) (0.011) (0.013) (0.016) (0.020)
old -0.022 -0.010 0.004 -0.002 -0.005
(0.024) (0.017) (0.018) (0.016) (0.029)
female 0.053 0.018 0.053 -0.068 -0.170
(0.050) (0.051) (0.045) (0.047) (0.124)
urban 0.055 0.013 0.022
(0.035) (0.017) (0.023)
agriculture 0.007 -0.001 0.003 0.001 0.015
(0.009) (0.006) (0.009) (0.008) (0.011)
manufacturing 0.008 -0.003 -0.015 0.014 0.020
(0.012) (0.011) (0.010) (0.011) (0.014)
education -0.003 0.026
(0.011) (0.017)
population density 0.000 -0.073
(0.016) (0.049)
CO2 0.013* -0.003
(0.007) (0.015)
health expenditure -0.006 -0.012
(0.012) (0.018)
Observations 2,347 3,642 3,470 3,158 1,936
Countries 161 168 168 168 158
AR(1) 0.000 0.000 0.000 0.000 0.000
AR(2) 0.395 0.505 0.621 0.525 0.274
Note: Dependent variable: Health Complexity Index (HCI). Main independent variable: GDP per
capita in logs (GDPpc). Regression analysis: One-step diff-GMM. All regressions include time dum-
mies. Robust standard errors are in parentheses. AR(1) and AR(2) are the p-values for first- and
second-order autocorrelated disturbances. * p<0.10, ** p<0.05, *** p<0.01
In Tables 5 and 6, we investigate the robustness of our baseline findings. First, we substitute
the HCI with the age-standardized health complexity index (AHCI) maintaining the same set
of controls (and time dummies) as in the baseline specification. Second, we investigate whether
the positive impact of economic development on health complexity persists under additional
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and/or alternative control measures (including time dummies). In all cases, the baseline results
remain qualitatively intact. In particular, the coefficient of GDPpc is positive and statistically
significant in the instrumented regressions (see Table 5; to save space, we only include the first-
stage estimated coefficients of the instruments – the results for the rest of the variables are
available upon request).
Table 6 starts from the baseline specification with the full set of controls [column (9) in Table
4] and introduces additional variables or alternative measures for some of the previous controls.
Specifically, in column (1), we add education (enrolment in secondary education in logs). In
column (2), we substitute the urban population variable with population density (people per sq.
km of land in logs). In columns (3) and (4), we employ (log) CO2 emissions (CO2 emissions, kg per
2010 $US of GDP) and (log) health expenditure (total health spending, thousands of 2017 PPP
adjusted $US), respectively. Finally, in column (5), we consider all of the above variables together.
Adding these controls in our estimations leaves the findings qualitatively and quantitatively
intact.
The above analysis suggests that economically developed countries tend to exhibit more complex
disease structures. Furthermore, exploiting the temporal variation in the data, the fixed-effects
2SLS/IV analysis and the difference GMM estimators reveal a positive, statistically significant,
and robust impact of economic development on health complexity.
6 Economic development and disease complexity
The economic complexity methodology provides a useful toolbox that allows us to compute in-
dices that quantify the complexity of both countries and diseases. For example, using the same
methodology that computes the HCI, but placing the spotlight on diseases rather than countries,
we calculate the DCI (see Section 3). This index quantifies the complexity of countries’ diseases
according to their prevalent cases worldwide. Using the economic complexity methodology, Hart-
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Figure 8: Matrix representation of the links between countries and diseases. A visu-
alization of this matrix for the year 2016, where a dark point indicates that country c has a RDD in a given
disease d. The matrix is sorted using the NODF algorithm [7], which highlights the existence of countries that
are very well diversified and countries that have prevalent cases only for a small set of diseases.
mann et al. [55] recently introduced a measure that associates products with income inequality
and showed how the development of new products is associated with changes in income inequal-
ity. Here, to decompose economic development at the disease level, we introduce a measure that
links a disease to the average income per capita of the countries in which the disease has preva-
lent cases i.e., an estimate of the expected income per capita related to different diseases. In this
way, we illustrate how disease complexity is being affected by the level of economic development
and quantify the relationship between countries’ income per capita and the complexity of their
diseases.
Following the methodology in Hartmann et al. [55], we define the Disease-Income Complexity
Index (DICI), and decompose the relationship between the DCI and the DICI for the prevalent
cases of diseases in our sample of countries.8
8We also computed the ADICI and investigated its relationship with the ADCI, finding similar results.
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6.1 Disease-income complexity index
Assuming that we have information for l countries and k diseases, we can fill the (l × k) matrix
M so that its matrix element Mcd = 1 if country c has a RDD in disease d, and zero otherwise
(see Section 3). Our dataset contains information for 195 developed and developing countries
and for 196 diseases from 1990 to 2016. A visualization of the matrix M that is used to calculate
the HCI and the DCI for this dataset is shown in Figure 8.
Every disease d can have prevalent cases in a country c. For every disease d, we can calculate
the fraction scd:
scd =
Xcd∑
d′ Xcd′
, (8)
where Xcd is the number of prevalent cases per 100,000 population for disease d in country c,
while
∑
d′ Xcd′ is the number of prevalent cases of all diseases in country c. If GDPc is the (log)
GDP per capita of country c, we can calculate the DICId for every disease d as:
DICId =
1
Nd
∑
c
McdscdGDPc, (9)
where Nd =
∑
cMcdscd is a normalization factor.
The DICI is defined at the disease level as the average level of (log) GDP per capita of the
countries that have a RDD in disease d, weighted by the disease’s importance in each country’s
pool of diseases. Utilizing the (log) PPP GDP per capita (constant 2011 international $) from
the World Bank’s World Development Indicators for the countries in our sample, we calculate
the above index for every year in the period of 1990-2016.
Table 7 lists the five diseases with the highest and lowest average DICI values during the period
of 1990-2016. It is evident that higher economic development is associated with more complex
diseases such as motor neuron disease and malignant skin melanoma. At the other end of the
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Figure 9: DICI against DCI. The solid line represents the fit of a linear model and the dashed line a
95% prediction interval based on the fitted linear model.
Table 7: List of the five diseases with the highest and lowest DICI values during the period of
1990-2016
code disease name disease section DICI DCI
Highest DICI
554 Motor neuron disease Neurological disorders 4.55 1.025
459 Malignant skin melanoma Neoplasms 4.52 1.210
573 Anorexia nervosa Mental disorders 4.49 0.818
483 Mesothelioma Neoplasms 4.49 1.041
485 Non-Hodgkin’s lymphoma Neoplasms 4.48 1.057
Lowest DICI
404 Acute hepatitis E Other infectious diseases 2.89 -1.707
345 Malaria Neglected tropical diseases and malaria 2.86 -2.045
353 Cystic echinococcosis Neglected tropical diseases and malaria 2.84 -1.383
370 Maternal obstructed labor and uterine rupture Maternal and neonatal disorders 2.80 -1.957
359 Rabies Neglected tropical diseases and malaria 2.76 -1.840
Notes: DICI: Disease-Income Complexity Index; DCI: Disease Complexity Index; Average values for 1990-2016
spectrum, less complex diseases such as acute hepatitis E and malaria are associated with low
levels of income per capita.
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6.2 Linking disease complexity and economic development
In this subsection, we test the existence of a bivariate relationship between the DCI and the
DICI. Thus, we calculate Pearson’s correlation coefficient for DICI against DCI. If such an
association exists, it should allow us to derive expectations about whether disease complexity
can be associated with economic development and verify, with disease-level data, the statistically
significant and positive relationship between health complexity and economic development that
we found above (Section 5.2). The correlation coefficient for the relationship between the average
values of the DICI and the DCI for the period of 1990-2016 is ρ = 0.96 ± 0.01 with a p-value
< 2.2× 10−16. In Figure 9, we present the scatter-plot of the relationship between the DICI and
the DCI for the 196 diseases in our dataset (average values for 1990-2016), together with the
fitted linear model. The slope of the linear fit is the corresponding correlation coefficient.
The statistically significant positive correlation between the DICI and the DCI indicates that
more complex diseases are associated with more developed countries, as measured by the (log)
GDP per capita. This allows us to understand which sets of diseases are linked to better overall
economic performance, based on their complexity.
In Table 8, we run panel regressions between the DCI and DICI. The results show that the rela-
tionship between the DCI and the DICI is the outcome of the correlations both between diseases
(regression on group means) and within diseases (fixed-effects regression with time dummies and
standard errors adjusted for disease clusters). This suggests that the positive effect of economic
development on the complexity of diseases is due to both changes in the structure of the disease
space towards more complex diseases and increases in the complexity of existing diseases.
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Table 8: Disease-income complexity index and the complexity of diseases
(1) (2)
DCI
Within Estimation
DCI
Between Estimation
DICI 0.479*** 2.041***
(0.149) (0.045)
Observations 5,211 5,211
Diseases 193 193
R-square 0.90 0.88
Notes: DICI: Disease-Income Complexity Index; DCI: Disease Complexity Index. Time dummies are included in
the within regression. Standard errors are in parentheses. * p<0.10, ** p<0.05, *** p<0.01
7 Conclusions
Our analysis illustrates that a country’s level of development determines the structure of its
disease space. Following the economic complexity methodology, we developed the HCI, which
quantifies the network representation of the relatedness and proximity of diseases. In a dynamic
panel data setting, we showed that there is a robust positive effect of a country’s economic devel-
opment, measured by GDP per capita, on its level of health complexity, i.e., on the ‘structural’
composition of its pool of diseases. The evidence presented here suggests that the economic de-
velopment of nations conditions the disease space. Specifically, more complex diseases tend to
have relatively more prevalent cases in populations with a higher income per capita. Explicitly,
it seems that when an economy accelerates, the impact on health complexity is positive.
In addition, we build the DICI, which links a disease to the average level of income per capita
of the countries in which the disease has prevalent cases and illustrate how disease complexity is
related to economic development. Specifically, we show how changes in GDP per capita are asso-
ciated with more complex diseases. The temporal variation of the above indices is important from
a policy perspective. Using the HCI and DCI, it is possible to design policies aimed at improving
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the recognition, visibility, and traceability of complex diseases across the globe and through time
(e.g., by developing a classification system for all health information systems). These indices can
also be used as tools for the development of national plans for complex diseases and the estab-
lishment of knowledge networks on complex diseases, so as to improve their diagnosis, treatment,
and cure. Furthermore, the DICI could be used to design a health expenditure reallocation policy
promoting health activities and services associated with the prevention of complex diseases.
This study employs the economic complexity methodology to compute two new metrics that
quantify the disease space of countries. These can be valuable tools for estimating the effect of
economic development on the health status of nations. The topic of economic complexity is a
rather new one, and its use in economics is rather limited so far. By focusing on the topic of
disease complexity, our contribution lies in bridging the health economics literature with the
literature that highlights economic complexity as a powerful paradigm in understanding key
issues in economics, geography, innovation studies, and other social sciences.
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